PharmaReports: Neurodegenerative & Neuroelectrophysiological Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focusses on the chronic neurodegenerative disorders. Reports investigating memory/cognitive decline are also listed here unless they are clearly unrelated to neurodegeneration. In addition, reports relating to acute neurodegeneration such as stroke and cerebral hemorrhage can be included here.
Showing results 1 - 50 of 142
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Proteomics - Technologies, Markets and Companies
- Neuroprotection - Drugs, Markets and Companies
- Transdermal Drug Delivery - Technologies, Markets, and Companies
- Nitric Oxide - Therapeutics, Markets and Companies
- Alzheimer disease - new drugs, markets and companies
- Gene Therapy - technologies, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Biomarkers - technologies,markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Cannabinoid Market Forecasts & Analysis to 2012
- Early Toxicology: Markets and Approaches
- Multiple Sclerosis World Market Outlook to 2011
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
- Cell-Based Assays for Drug Discovery
- Personalized Medicine
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- ALZHEIMER DISEASE - Therapy Area Pipeline Report
- EPILEPSY - Therapy Area Pipeline Report
- PARKINSON DISEASE - Therapy Area Pipeline Report
- SEIZURES - Therapy Area Pipeline Report
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- Coxibs - Past Problems and Future Potential
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- How to Conduct Clinical Trials in China
- Alzheimers Disease Market analysis and forecasts, 2007-2022
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Parkinson's Disease Market analysis and forecasts
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Neuronal Nicotinic Receptors - April 2008
- Outsourcing in Drug Discovery
- Neuronal Nicotinic Receptors - June 2008
- Neuronal Nicotinic Receptors - July 2008
- The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Neuronal Nicotinic Receptors - August 2008
- Neuronal Nicotinic Receptors - September 2008
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development